Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Journal:
Current Pharmaceutical Biotechnology
Volume:
11
Page:
545-554
Author(s):
Lance T. Hall, Aaron F. Struck and Scott B. Perlman
Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
398-408
Author(s):
Zhiwei Wang, Yiwei Li and Fazlul H. Sarkar
Recent Progress in Phosphoinositide 3-Kinases: Oncogenic Properties and Prognostic and Therapeutic Implications
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
425-435
Author(s):
Guojun Wu
Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Journal:
Current Protein & Peptide Science
Volume:
11
Page:
471-484
Author(s):
Ivan Stamenkovic and Qin Yu
Tyrosine Kinase Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
462-483
Author(s):
C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli
Vascular Disrupting Agents (VDAs) in Anticancer Therapy
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
178-185
Author(s):
Laura G.M. Daenen, Jeanine M.L. Roodhart, Yuval Shaked and Emile E. Voest
DNA Instability at Chromosomal Fragile Sites in Cancer
Journal:
Current Genomics
Volume:
11
Page:
326-337
Author(s):
Laura W. Dillon, Allison A. Burrow and Yuh-Hwa Wang
C-11 Radiochemistry in Cancer Imaging Applications
Journal:
Current Topics in Medicinal Chemistry
Volume:
10
Page:
1060-1095
Author(s):
Z. Tu and R.H. Mach
PET with Non-Standard Nuclides
Journal:
Current Topics in Medicinal Chemistry
Volume:
10
Page:
1096-1112
Author(s):
Guiyang Hao, Ajay N Singh, Wei Liu and Xiankai Sun
Clinical Uses of Melatonin: Evaluation of Human Trials
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2070-2095
Author(s):
E.J. Sanchez-Barcelo, M.D. Mediavilla, D.X. Tan and R.J. Reiter